Hang Liu

Hang Liu

Auto-generated profile, based on publicly available information

Hang Liu

School of Medicine, Guizhou University, Guiyang, China

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
YZYuanling Zhang
Yuanling Zhang
Junhao ChenJunhao Chen
Junhao Chen
HLHang Liu
Hang Liu
RMRui Mi
Rui Mi
RHRui Huang
Rui Huang
JDJIE DING
JIE DING
Epigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methylase and histone demethylase to stabilize transcription levels in the promoter area, is one of the most common types of epigenetic alteration, which gained increasing interest. It can modify gene transcription through chromatin structure and affect cell fate, at the transcriptome or protein level. According to recent research, histone methylation modification can regulate tumor and immune cells affecting anti-tumor immune response. Consequently, it is critical to have a thorough grasp of the role of methylation function in cancer treatment. In this review, we discussed recent data on the mechanisms of histone methylation on factors associated with immune resistance of tumor cells and regulation of immune cell function.